Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity

[1]  C. Masters,et al.  Amyloid-β Peptide (Aβ) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: Aβ Dimers and Trimers Correlate with Neurotoxicity , 2008, The Journal of Neuroscience.

[2]  C. Masters,et al.  The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. , 2008, Biophysical journal.

[3]  C. Masters,et al.  Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.

[4]  S. Bottomley,et al.  Stabilization of Neurotoxic Soluble β-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-β Peptide , 2008 .

[5]  R. Cappai,et al.  Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity , 2008, Neurochemical Research.

[6]  N. Arispe,et al.  The Cell-Selective Neurotoxicity of the Alzheimer's Aβ Peptide Is Determined by Surface Phosphatidylserine and Cytosolic ATP Levels. Membrane Binding Is Required for Aβ Toxicity , 2007, The Journal of Neuroscience.

[7]  R. Cappai,et al.  Molecular determinants of Alzheimer’s disease Aβ peptide neurotoxicity , 2007 .

[8]  J. McLaurin,et al.  Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding , 2007, BMC Neuroscience.

[9]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[10]  V. Szalai,et al.  Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease. , 2007, Journal of the American Chemical Society.

[11]  C. Masters,et al.  Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. , 2007, Biochemistry.

[12]  C. Masters,et al.  Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge* , 2006, Journal of Biological Chemistry.

[13]  F. Blankenberg,et al.  Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia , 2006, Neurology.

[14]  C. Masters,et al.  Amyloid-β Peptide Disruption of Lipid Membranes and the Effect of Metal Ions , 2006 .

[15]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[16]  C. Masters,et al.  Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity* , 2005, Journal of Biological Chemistry.

[17]  C. Masters,et al.  Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution* , 2004, Journal of Biological Chemistry.

[18]  C. Masters,et al.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  B. Penke,et al.  Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease , 2004 .

[20]  J. H. Viles,et al.  Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. , 2004, The Journal of biological chemistry.

[21]  D. Butterfield,et al.  Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease , 2004, Brain Research.

[22]  A. Herrmann,et al.  Tracking down lipid flippases and their biological functions , 2004, Journal of Cell Science.

[23]  B. Penke,et al.  Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease. , 2004, Current protein & peptide science.

[24]  Xudong Huang,et al.  Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. , 2004, Biochemistry.

[25]  C. Masters,et al.  Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation* , 2003, Journal of Biological Chemistry.

[26]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Bettina Schmitt,et al.  Selection of D‐Amino‐Acid Peptides That Bind to Alzheimer's Disease Amyloid Peptide Aβ1–42 by Mirror Image Phage Display , 2003, Chembiochem : a European journal of chemical biology.

[28]  L. Lankiewicz,et al.  Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study. , 2003, Journal of inorganic biochemistry.

[29]  Bradley D. Smith,et al.  Facilitated phosphatidylserine (PS) flip-flop and thrombin activation using a synthetic PS scramblase. , 2003, Journal of the American Chemical Society.

[30]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[31]  D. Daleke.  Regulation of transbilayer plasma membrane phospholipid asymmetry Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.R200019-JLR200 , 2003, Journal of Lipid Research.

[32]  H. Pollard,et al.  Annexin 5 and apolipoprotein E2 protect against Alzheimer’s amyloid-β-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site , 2002, Peptides.

[33]  B. Gilchrest,et al.  Amyloid β Binds Trimers as Well as Monomers of the 75-kDa Neurotrophin Receptor and Activates Receptor Signaling* , 2002, The Journal of Biological Chemistry.

[34]  Theresa A. Good,et al.  Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of β-Amyloid Peptides* , 2001, The Journal of Biological Chemistry.

[35]  G. Bitan,et al.  Amyloid (cid:1) -Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS* , 2001 .

[36]  W. Müller,et al.  Membrane-disordering effects of β-amyloid peptides , 2001 .

[37]  J. Kourie.  Mechanisms of Amyloid β Protein-Induced Modification in Ion Transport Systems: Implications for Neurodegenerative Diseases , 2001, Cellular and Molecular Neurobiology.

[38]  C. Masters,et al.  Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons , 2001, Neurobiology of Disease.

[39]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[40]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Cotman,et al.  All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids* , 1997, The Journal of Biological Chemistry.

[42]  X. Chen,et al.  RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.

[43]  W. Cho,et al.  Interactions of annexin V with phospholipid monolayers. , 1996, Biochimica et biophysica acta.

[44]  H. Hemker,et al.  Clustering of lipid-bound annexin V may explain its anticoagulant effect. , 1992, The Journal of biological chemistry.

[45]  M. Frotscher,et al.  Reduction of posttraumatic transneuronal "early gene" activation and dendritic atrophy by the N-methyl-D-aspartate receptor antagonist MK-801. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Herbette,et al.  Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol , 1992, Neurobiology of Aging.

[47]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[48]  R. Martins,et al.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. , 1985, The EMBO journal.

[49]  M. Bretscher.  Asymmetrical lipid bilayer structure for biological membranes. , 1972, Nature: New biology.

[50]  N. Arispe.  Architecture of the Alzheimer’s AβP Ion Channel Pore , 2003, The Journal of Membrane Biology.

[51]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[52]  S. N. Timasheff,et al.  The measurement of cooperative protein self-assembly by turbidity and other techniques. , 1986, Methods in enzymology.